Phibro Animal Health (PAHC) Declares $0.10 Quarterly Dividend; 1.2% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
Go back to Phibro Animal Health (PAHC) Declares $0.10 Quarterly Dividend; 1.2% Yield
May 11, 2015 4:45 PM EDT
TEANECK, N.J., May 11, 2015 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (Nasdaq: PAHC) today announced its financial results for its third quarter ended March 31, 2015.
Highlights for the March 2015 quarter (compared to the March 2014 quarter)
Net sales of $187 million, an increase of 8%
Adjusted EBITDA of $27.5 million, an increase of 23%
Adjusted diluted EPS of $0.41
COMMENTARY
Commenting on the quarter, Jack Bendheim, Phibro's Chairman, President and Chief Executive Officer, said, "We are pleased with the development of our Animal Health and Mineral... More
May 11, 2015 4:45 PM EDT
TEANECK, N.J., May 11, 2015 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (Nasdaq: PAHC) today announced its financial results for its third quarter ended March 31, 2015.
Highlights for the March 2015 quarter (compared to the March 2014 quarter)
Net sales of $187 million, an increase of 8%
Adjusted EBITDA of $27.5 million, an increase of 23%
Adjusted diluted EPS of $0.41
COMMENTARY
Commenting on the quarter, Jack Bendheim, Phibro's Chairman, President and Chief Executive Officer, said, "We are pleased with the development of our Animal Health and Mineral... More
May 11, 2015 4:15 PM EDT
TEANECK, N.J., May 11, 2015 (GLOBE NEWSWIRE) -- The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today announced the appointment of Dr. George Gunn as a Class III director of the company, effective immediately. Dr. Gunn will be an independent director. Dr. Gunn's appointment expands the Board to 8 directors, 5 of whom are independent directors. Dr. Gunn will also be a member of the company's Compensation Committee.
Dr. Gunn has over thirty years' experience in the animal health industry. Most recently, Dr. Gunn was the global head of Novartis AG's Animal Health... More
May 11, 2015 4:15 PM EDT
TEANECK, N.J., May 11, 2015 (GLOBE NEWSWIRE) -- The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today announced the appointment of Dr. George Gunn as a Class III director of the company, effective immediately. Dr. Gunn will be an independent director. Dr. Gunn's appointment expands the Board to 8 directors, 5 of whom are independent directors. Dr. Gunn will also be a member of the company's Compensation Committee.
Dr. Gunn has over thirty years' experience in the animal health industry. Most recently, Dr. Gunn was the global head of Novartis AG's Animal Health... More
